|
|
Xceed Capital Limited - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Xceed Capital Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Xceed Capital Limited Formerly known as Xceed Biotechnology Limited. The Group's principal activities are the developing and commercialising biodegradable polymers, selling chemical products and working with collaborative partners in identifying additional investment opportunities in the Life Science sector. Its businesses are carried out through its two subsidiaries. PolyNovo develops new generation treatments for use in medical devices, while Boron Molecular provides unique building-block compounds and specialist chemistry services to the global pharmaceutical, fine chemicals and materials market.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|